Loading...
Image courtesy: Meredith Kulwicki, University at Buffalo
Prof. Arany is a renowned expert in PBM, and his research has focused on clinical translation and molecular mechanisms. Some of his major contributions to the field include the adoption of the standard nomenclature of PBM as a PubMed MeSH term, demonstrating a novel PBM molecular mechanism involving latent TGF-beta 1 activation that drives tissue resilience, regeneration, and immunomodulation, outlining clinical biomarkers (tissue surface temperature), molecular biomarkers (ATF-4), treatment delivery (target surface irradiance), and dosimetry (Photonic fluence and Einstein) for safe and effective PBM clinical protocols. This has resulted in clinical practice guideline recommendations for treating several human diseases and promoting wellness, especially in supportive cancer care.
Dr. Arany has served as an Assistant Clinical Investigator at the NIDCR, National Institutes of Health. He has received several awards recognizing his contributions, including the Horace Furumoto Young Investigator ASLMS award from ASLMS, the T. H. Maiman Award for Excellence in Dental Laser Research from the Academy of Laser Dentistry, and the NIH NCI Young Investigator Award. He has over 150 scientific publications with over 8000 citations and 6 patents that include his recent work with PBM on long-COVID and preventing cardiovascular aging with the National Institute on Aging, NIH. He has served in WALT as the scientific chair, executive committee, immediate past president, and is currently the executive director.
PARK PLAZA WESTMINSTER LONDON
200 Westminster Bridge Rd, London SE1
7UT, United Kingdom